Literature DB >> 17272749

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.

Adi Mor1, David Planer, Galia Luboshits, Arnon Afek, Shula Metzger, Tova Chajek-Shaul, Gad Keren, Jacob George.   

Abstract

OBJECTIVE: Naturally occurring CD4+ CD25+ regulatory T cells (Tregs) exert suppressive effects on effector CD4 cells and downregulate experimental autoimmune disorders. We investigated the importance and potential role of Tregs in murine atherogenesis. METHODS AND
RESULTS: Tregs were investigated comparatively between aged and young apolipoprotein E-knockout (ApoE-KO) mice and age-matched C57BL/6 littermates. The effect of oxidized LDL (oxLDL) was tested on the functional suppressive properties of Tregs from ApoE-KO and C57BL/6 mice. Tregs, CD4+ CD25- cells, and saline were infused into ApoE-KO mice to study their effects on atherogenesis. Treg numbers were reduced in atherosclerotic compared with nonatherosclerotic ApoE-KO mice. The functional suppressive properties of Tregs from ApoE-KO mice were compromised in comparison with those from their C57BL/6 littermates. Thus, oxLDL attenuated the suppressive properties of Tregs from C57BL/6 mice and more so in ApoE-KO mice. Transfer of Tregs from age-matched ApoE-KO mice resulted in significant attenuation of atherosclerosis compared with that after delivery of CD4+ CD25+/- T cells or phosphate-buffered saline.
CONCLUSIONS: CD4+ CD25+ Tregs may play a protective role in the progression of atherosclerosis and could be considered a therapeutic tool if results from human studies can solidify observations in murine models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272749     DOI: 10.1161/01.ATV.0000259365.31469.89

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  111 in total

1.  Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques.

Authors:  Zhen-dong Liu; Lin Wang; Fang-hong Lu; Hui Pan; Ying-xin Zhao; Shu-jian Wang; Shang-wen Sun; Cui-ling Li; Xiao-liang Hu
Journal:  Inflamm Res       Date:  2012-06-23       Impact factor: 4.575

2.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

Review 3.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 4.  The role of adaptive T cell immunity in atherosclerosis.

Authors:  Ziad Mallat; Soraya Taleb; Hafid Ait-Oufella; Alain Tedgui
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

5.  Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction.

Authors:  Qing Li; Yiping Wang; Feng Yu; Yuan Min Wang; Cuiping Zhang; Chaojie Hu; Zhiwei Wu; Xiucai Xu; Shilian Hu
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

6.  The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.

Authors:  Jing Lin; Ming Li; Zhixiao Wang; Shaolin He; Xuming Ma; Dazhu Li
Journal:  J Lipid Res       Date:  2009-12-10       Impact factor: 5.922

Review 7.  The immune system in atherosclerosis.

Authors:  Göran K Hansson; Andreas Hermansson
Journal:  Nat Immunol       Date:  2011-03       Impact factor: 25.606

Review 8.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

9.  miR-21 alters circulating Treg function in vascular disease-hope for restoring immunoregulatory responses in atherosclerosis?

Authors:  Emer E Hackett; Frederick J Sheedy
Journal:  Ann Transl Med       Date:  2017-01

10.  Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.

Authors:  Roland Klingenberg; Norbert Gerdes; Robert M Badeau; Anton Gisterå; Daniela Strodthoff; Daniel F J Ketelhuth; Anna M Lundberg; Mats Rudling; Stefan K Nilsson; Gunilla Olivecrona; Stefan Zoller; Christine Lohmann; Thomas F Lüscher; Matti Jauhiainen; Tim Sparwasser; Göran K Hansson
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.